CHARACTERIZATION OF THE RESPONSE OF GROWTH AND DIFFERENTIATION TO LIPOPROTEINS AND AGENTS AFFECTING CHOLESTEROL-METABOLISM IN MURINE NEUROBLASTOMA-CELLS
F. Castellano et al., CHARACTERIZATION OF THE RESPONSE OF GROWTH AND DIFFERENTIATION TO LIPOPROTEINS AND AGENTS AFFECTING CHOLESTEROL-METABOLISM IN MURINE NEUROBLASTOMA-CELLS, International journal of developmental neuroscience, 12(1), 1994, pp. 77-84
Treatment with mevinolin, a competitive inhibitor of HMGCoAR, the key
enzyme of isoprenoid metabolism, causes the arrest of proliferation an
d the differentiation of a neuroblastoma cell line (N18TG2). Mevalonat
e and high density lipoproteins partially restore growth. Cholesterol
synthesis in the presence of mevinolin remains active, because in thes
e cells the key enzyme HMG-CoA reductase is not completely inhibited b
y this drug. The fact that cell growth is reduced, while cholesterogen
esis remains active, suggests that mevinolin acts by interfering with
the synthesis of some unknown compound, other than cholesterol, which
is necessary for proliferation.